Methods and issues in studies of CRE

Virulence

Volumn 8, Issue 4, 2017, Pages 453-459

  Evans, Scott R ^a   Harris, Anthony D ^b  

^a CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

carbapenem resistant Enterobacteriaceae; case control study; cohort study; competing risk; confounding variable; control group; external control; lead time bias; randomized trial

Indexed keywords

CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CASE CONTROL STUDY; COHORT ANALYSIS; CONFOUNDING VARIABLE; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; HUMAN; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTIINFECTIVE AGENT;

ANTI-BACTERIAL AGENTS; CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; CASE-CONTROL STUDIES; COHORT STUDIES; ENTEROBACTERIACEAE INFECTIONS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84981710205     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.1080/21505594.2016.1213473     Document Type: Review

References (30)

1. Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, Kallen A, Limbago B, Fridkin S,; National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities. Antimicrobial-resistant pathogens associated with healthcare-associated infections:Summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2009–2010. Infect Control Hosp Epidemiol 2013; 34(1):1-14; PMID:23221186; https://doi.org/10.1086/668770
2. Centers for Disease Control and Prevention (CDC). Biggest threats. http://www.cdc.gov/drugresistance/biggest_threats.html. Accessed 04/14/2015.
3. Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia, PA:Lippincott Williams & Wilkins; 2008.
4. Dohoo I, Martin W, Stryhn H. Methods in epidemiologic research. Prince Edward Island, Canada:VER, Inc; 2012.
5. Harris AD, Samore MH, Lipsitch M, Kaye KS, Perencevich E, Carmeli Y. Control-group selection importance in studies of antimicrobial resistance:Examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli. Clin Infect Dis 2002; 34(12):1558-63; PMID:12032889; https://doi.org/10.1086/340533
6. Harris AD, Samore MH, Carmeli Y. Control group selection is an important but neglected issue in studies of antibiotic resistance. Ann Intern Med 2000; 133(2):159; PMID:10896645; https://doi.org/10.7326/0003-4819-133-2-200007180-00018
7. Schechner V, Temkin E, Harbarth S, Carmeli Y, Schwaber MJ. Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance. Clin Microbiol Rev 2013; 26(2):289-307. [PMC3623381]; PMID:23554418; https://doi.org/10.1128/CMR.00001-13
8. Kaye KS, Harris AD, Samore M, Carmeli Y. The case-case-control study design:Addressing the limitations of risk factor studies for antimicrobial resistance. Infect Control Hosp Epidemiol 2005; 26(4):346-51; PMID:15865269; https://doi.org/10.1086/502550
9. Gordis L. Epidemiology. 2nd ed. Philadelphia:W.B. Saunders Company; 2000.
10. Hosmer DW, Lemeshow H, May S. Applied survival analysis:Regression modeling of time-to-event data. 2nd ed. Hoboken, NJ:John Wiley & Sons, Inc; 2008.
11. Hosmer DW, Lemeshow S, Sturdivant RX. Applied logistic regression. 3rd ed. New York:Wiley; 2013:528.
12. McGregor JC, Perencevich EN, Furuno JP, Langenberg P, Flannery K, Zhu J, Fink JC, Bradham DD, Harris AD. Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections. J Clin Epidemiol 2006; 59(12):1266-73; PMID:17098569; https://doi.org/10.1016/j.jclinepi.2006.01.016
13. McGregor JC, Kim PW, Perencevich EN, Bradham DD, Furuno JP, Kaye KS, Fink JC, Langenberg P, Roghmann MC, Harris AD. Utility of the chronic disease score and charlson comorbidity index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms. Am J Epidemiol 2005; 161(5):483-93; PMID:15718484; https://doi.org/10.1093/aje/kwi068
14. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and candida. Ann Intern Med. 2002; 136(11):834-44; PMID:12044132; https://doi.org/10.7326/0003-4819-136-11-200206040-00013
15. Tsiodras S, Pittet D, Carmeli Y, Eliopoulos G, Boucher H, Harbarth S. Clinical implications of Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole:A study of 69 patients at 2 university hospitals. Scand J Infect Dis 2000; 32(6):651-6; PMID:11200376; https://doi.org/10.1080/003655400459577
16. Marcos M, Inurrieta A, Soriano A, Martínez JA, Almela M, Marco F, Mensa J. Effect of antimicrobial therapy on mortality in 377 episodes of enterobacter spp bacteraemia. J Antimicrob Chemother 2008; 62(2):397-403; PMID:18420813; https://doi.org/10.1093/jac/dkn155
17. Harris AD, Karchmer TB, Carmeli Y, Samore MH. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance:A systematic review. Clin Infect Dis 2001; 32(7):1055-61; PMID:11264034; https://doi.org/10.1086/319600
18. Wolkewitz M, Allignol A, Harbarth S, de Angelis G, Schumacher M, Beyersmann J. Time-dependent study entries and exposures in cohort studies can easily be sources of different and avoidable types of bias. J Clin Epidemiol 2012; 65(11):1171-80; PMID:23017635; https://doi.org/10.1016/j.jclinepi.2012.04.008
19. Beyersmann J, Kneib T, Schumacher M, Gastmeier P. Nosocomial infection, length of stay, and time-dependent bias. Infect Control Hosp Epidemiol 2009; 30(3):273-6; PMID:19193018; https://doi.org/10.1086/596020
20. Schumacher M, Allignol A, Beyersmann J, Binder N, Wolkewitz M. Hospital-acquired infections–appropriate statistical treatment is urgently needed! Int J Epidemiol 2013; 42(5):1502-8; PMID:24038717; https://doi.org/10.1093/ije/dyt111
21. De Angelis G, Allignol A, Murthy A, Wolkewitz M, Beyersmann J, Safran E, Schrenzel J, Pittet D, Harbarth S. Multistate modelling to estimate the excess length of stay associated with meticillin-resistant Staphylococcus aureus colonisation and infection in surgical patients. J Hosp Infect 2011; 78(2):86-91; PMID:21481492; https://doi.org/10.1016/j.jhin.2011.02.003
22. Schmoor C, Schumacher M, Finke J, Beyersmann J. Competing risks and multistate models. Clin Cancer Res 2013; 19(1):12-21; PMID:23172882; https://doi.org/10.1158/1078-0432.CCR-12-1619
23. Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol 2000; 29(4):722-9; PMID:10922351; https://doi.org/10.1093/ije/29.4.722
24. Food and Drug Administration, HHS. International conference on harmonisation; choice of control group and related issues in clinical trials; availability. notice. Fed Regist 2001; 66(93):24390-1; PMID:12356096
25. Sacks H, Chalmers TC, Smith H, Jr. Randomized versus historical controls for clinical trials. Am J Med 1982; 72(2):233-40; PMID:7058834; https://doi.org/10.1016/0002-9343(82)90815-4
26. Patulin Clinical Trials Committee, Medical Research Council. Clinical trial of patulin in the common cold. 1944. Int J Epidemiol 2004; 33(2):243-6; PMID:15082620; https://doi.org/10.1093/ije/dyh028
27. Stafford KA, Boutin M, Evans SR, Harris AD. Difficulties in demonstrating superiority of an antibiotic for multidrug-resistant bacteria in nonrandomized studies. Clin Infect Dis 2014; 59(8):1142-7. [PMC4271096]; PMID:24982037; https://doi.org/10.1093/cid/ciu486
28. Rosenberger LH, LaPar DJ, Sawyer RG. Infections caused by multidrug resistant organisms are not associated with overall, all-cause mortality in the surgical intensive care unit:The 20,000 foot view. J Am Coll Surg 2012; 214(5):747-55. [PMC3334453]; PMID:22421258; https://doi.org/10.1016/j.jamcollsurg.2012.01.040
29. Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ. Deaths attributable to carbapenem-resistant enterobacteriaceae infections. Emerg Infect Dis 2014; 20(7):1170-5. [PMC4073868]; PMID:24959688; https://doi.org/10.3201/eid2007.121004
30. Gehan EA. The evaluation of therapies:Historical control studies. Stat Med 1984; 3(4):315-24; PMID:6528131; https://doi.org/10.1002/sim.4780030405